Global TravEpiNet: a national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
LaRocque Regina C, Rao Sowmya R, Lee Jennifer, Ansdell Vernon, Yates Johnnie A, Schwartz Brian S, Knouse Mark, Cahill John, Hagmann Stefan, Vinetz Joseph, Connor Bradley A, Goad Jeffery A, Oladele Alawode, Alvarez Salvador, Stauffer William, Walker Patricia, Kozarsky Phyllis, Franco-Paredes Carlos, Dismukes Roberta, Rosen Jessica, Hynes Noreen A, Jacquerioz Frederique, McLellan Susan, Hale Devon, Sofarelli Theresa, Schoenfeld David, Marano Nina, Brunette Gary, Jentes Emily S, Yanni Emad, Sotir Mark J, Ryan Edward T, Global TravEpiNet Consortium
Аннотация
METHODS: We formed a national consortium (Global TravEpiNet) of 18 US clinics registered to administer yellow fever vaccination. We collected data regarding demographic and health characteristics, destinations, purpose of travel, and pretravel healthcare from 13235 international travelers who sought pretravel consultation at these sites from January 2009 through January 2011.
RESULTS: The destinations and itineraries of Global TravEpiNet travelers differed from those of the overall population of US international travelers. The majority of Global TravEpiNet travelers were visiting low- or lower-middle-income countries, and Africa was the most frequently visited region. Seventy-five percent of travelers were visiting malaria-endemic countries, and 38% were visiting countries endemic for yellow fever. Fifty-nine percent of travelers reported ≥1 medical condition. Atovaquone/proguanil was the most commonly prescribed antimalarial drug, and most travelers received an antibiotic for self-treatment of travelers' diarrhea. Hepatitis A and typhoid were the most frequently administered vaccines.
CONCLUSIONS: Data from Global TravEpiNet provide insight into the characteristics and pretravel healthcare of US international travelers who are at increased risk of travel-associated illness due to itinerary, purpose of travel, or existing medical conditions. Improved understanding of this epidemiologically significant population may help target risk-reduction strategies and interventions to limit the spread of infections related to global travel.